The National Health Service (General Medical and Pharmaceutical Services) (Scotland) Amendment Regulations 1989

• Citation: S.I. 1989/1883
• Sections: 10

Section 1 Citation, commencement and interpretation

(1) These Regulations may be cited as the National Health Service (General Medical and Pharmaceutical Services) (Scotland) Amendment Regulations 1989 and shall come into force for all purposes except regulation 6 on 7th November 1989 and for the purposes of regulation 6 on 1st December 1989.

(2) In these Regulations “the principal Regulations ” means the National Health Service (General Medical and Pharmaceutical Services) (Scotland) Regulations 1974 .

Section 2 Amendments to the principal Regulations

In regulation 2(1) (interpretation) of the principal Regulations after the definition of “practice area” there shall be inserted the following definition:—

“provisional pharmaceutical list” means the list referred to in regulation 28A;

Section 3 Amendment to regulation 27

(1) For regulation 27 of the principal Regulations there shall be substituted the following regulation:—

Terms of service

(27)

(1) The arrangements for the provision of pharmaceutical services shall include arrangements for—

(a) the supply of contraceptive substances and appliances; and

(b) the provision of supplemental services.

(2) The arrangements referred to in paragraph (1) shall incorporate as appropriate the terms of service for chemists as set forth in Part I or, as the case may be, Part II of Schedule 3 to these Regulations.

(3) In this Part of these Regulations “supplemental services” means—

(a) where a chemist regularly supplies drugs and medicines to be taken by persons resident in a home, the giving of advice by him or, where he is not a pharmacist, by a pharmacist employed by him, following a visit to that home in connection with procedures there for the safe keeping and correct administration of those drugs and medicines;

(b) the keeping of records of such visits as are referred to in sub-paragraph (a);

(c) the keeping of records in connection with drugs and medicines supplied to or to be taken by any person—

(i) who claims exemption under regulation 7(1)(c) of the National Health Service (Charges for Drugs and Appliances) (Scotland) Regulations 1989 (exemption from charges for drugs and appliances), or

(ii) who, in the opinion of the pharmacist dispensing the drug or medicine, is likely to have difficulty understanding the nature and dosage of the drug or medicine dispensed and the times at which it is to be taken,

in circumstances where the nature of the drug or medicine is such that, in the opinion of the pharmacist who dispenses it, the same or a similar drug or medicine is likely to be prescribed for that person regularly on future occasions.

(4) In paragraph (3)—

(a) “home” means any one of—

(i) a nursing home within the meaning of the Nursing Homes Registration (Scotland) Act 1938 , or

(ii) a residential or other establishment within the meaning of Part IV of the Social Work (Scotland) Act 1968 , or

(iii) a private hospital within the meaning of Part IV of the Mental Health (Scotland) Act 1984 ;

(b) “pharmacist” means a pharmacist within the meaning of section 132(1) of the Medicines Act 1968 ;

(c) “records” shall include—

(i) in the case of those kept pursuant to paragraph (3)(b), a record of the name and address of the home, of the date of each visit and of the nature of any advice given in the course of or following each such visit and to whom it was given, and

(ii) in the case of those kept pursuant to paragraph (3)(c), a record of the name and address of the person to or for whom the drug or medicine is supplied, of the name, quantity, and dosage of the drug or medicine supplied and of the date on which the supply was made and any advice given in relation to the use of the drugs and medicines supplied.

(5) A chemist may at any time give notice in writing to the Board that he wishes to be—

(a) included in or excluded from any arrangements for the supply of contraceptive services and appliances, or

(b) included in any arrangements for the provision of supplemental services.

Section 4 New regulation 28A

(1) Regulation 28A of the principal Regulations shall be renumbered 28B and there shall be inserted the following new regulation:—

Provisional Pharmaceutical List

(28A)

(1) The Board may also in accordance with this regulation prepare a list, to be called “the provisional pharmaceutical list” in which there shall be included the name of any person, other than a doctor or dentist, who undertakes provisionally to provide pharmaceutical services. The provisional pharmaceutical list shall state the particulars required under regulation 28(1) in relation to any such person and also the date (“the provisional date”) from which such per son undertakes to provide pharmaceutical services at the premises specified in an application under regulation 28(2).

(2) Where in an application to which regulation 28(4) applies—

(a) any one or more of the statements in paragraph 2(b) of Form A is negative, and

(b) the Board is satisfied on the basis of such information as may be submitted with the application that the applicant intends to commence business at the premises specified in the application in the event of his name being included in the pharmaceutical list,

the Board shall notify and otherwise deal with the application in accordance with regulation 28(4) and Schedule 3A and where the Board grants the application in accordance with that regulation, the Board may include the name of the applicant in the provisional pharmaceutical list for its area.

(3) Where an application is determined by the inclusion of the name of the applicant in the provisional pharmaceutical list, the Board shall give notification of the decision to the applicant in Form D, and in this regulation any reference to “the date of inclusion” is to the date of inclusion in the provisional pharmaceutical list as stated on Form D.

(4) Subject to paragraph (5) the applicant shall, as soon as reasonably possible after the date of inclusion and in any event not later than either—

(a) the date six months after the date of inclusion, or

(b) if earlier, the provisional date,

submit Form B with the information required but not given in paragraph 2(b) of Form A and on receipt of such information the Board shall include the name of the applicant in the pharmaceutical list and remove it from the provisional pharmaceutical list.

(5) Where a person whose name has been included in the provisional pharmaceutical list applies in writing to the Board not later than twenty eight days before the date by which, in terms of paragraph (4), he is required to submit Form B, that he wishes the Board to extend the period for submission of that Form and the Board is satisfied that, due to circumstances outwith that person’s control and which could not reasonably have been anticipated at the date of the application, there is no reasonable prospect of his being able to submit that Form by that date, the Board may extend the period for submission of Form B by a further period not exceeding nine months.

(6) Where an applicant, whose name is included in the provisional pharmaceutical list, has not submitted Form B in accordance with paragraphs (4) or (5), his name shall be removed from the provisional list.

Section 5 Amendment to regulation 32 (payments to chemists and standards of drugs and appliances)

There shall be inserted after paragraph (d) of regulation 32 of the principal Regulations, the following sub-paragraph:—

(dd) arrangements for claiming fees, allowances and remuneration in connection with the making and implementation of arrangements for the provision of pharmaceutical services.

Section 6 Amendments to Schedule 2A

In Schedule 2A to the principal Regulations (drugs and other substances not to be supplied by general medical practitioners or prescribed for supply under pharmaceutical services) —

(a) the following entry shall be deleted:—

Ener-G Gluten-free and Yeast-free Brown Rice Bread; and

(b) each of the following entries shall be inserted at the appropriate point in alphabetical order:

Alexitol Sodium Tablets

Anadin Paracetamol Tablets

Aspirin Tablets, Effervescent Soluble

Aspro Clear Extra Tablets

Banimax Tablets

Boots Hard Lens Wetting Solution

Calamage

Colgate Disclosing Tablets

Contactasol 02 Care Solution

Contactasol Complete Care all-in-one Solution

Cow & Gate Premium Baby Food

Evident Disclosing Cream

Ferrol

Innoxa Finishing Touch Loose Powder

Innoxa Moisturised Liquid Make-Up

Lucozade

Milupa Aptamil Baby Milk

Milupa Camomile Infant Drink

Milupa Fennel Variety Infant Drink

Milupa Modified Yoghurt

Minoxidil Cream

Minoxidil Ointment

Minoxidil Solution (for external use)

Oral B Plaque Check Disclosing Tablets

Rabenhorst Tomato Juice

Ribena

RoC Eye Make-Up Remover Lotion

Senlax Tablets

Setlers Extra Strength Tablets.

Section 7 Amendments to Schedule 3 to the principal Regulations

In Part I of Schedule 3 (terms of service for chemists),

(a) after paragraph 2 there shall be inserted the following paragraph:—

Professional standards

(2A) Without prejudice to any rule or implication of law to that effect, a chemist who provides pharmaceutical services in accordance with arrangements made in the Regulations shall do so in conformity with standards generally accepted in the pharmaceutical profession.

(b) after paragraph 7 there shall be inserted the following paragraph:—

Records to be made available

(7A) A chemist who has undertaken to provide supplemental services within the meaning of paragraph (3) of regulation 27 shall on request make available to the Board all records kept in accordance with sub-paragraphs (b) and (c) of that paragraph.

Section 8 Amendment of Schedule 3A to the principal Regulations

In Part I of Schedule 3A for the heading and sub-paragraph (1) there shall be substituted the following:—

Receipt and notification of applications

(1)

(1) The Board shall, within five working days of receiving an application to which regulation 28(4) applies, give written notice of the application to—

(a) the area pharmaceutical committee;

(b) the area medical committee;

(c) any person whose name is included in the pharmaceutical list or the provisional pharmaceutical list and whose interests may, in the opinion of the Board, be significantly affected if the application were granted;

(d) any Board whose boundary is within one mile of the proposed premises;

(e) any local health council whose area is affected by the application,

and any person or body so notified may, within 30 days from the date on which the notification was sent to him, make written representations about the application to the Board.

(2) In paragraph 1(2)(c) after the words “pharmaceutical list” there shall be added the words “and the provisional pharmaceutical list”.

(3) After paragraph 2(1)(a) there shall be added a new sub-paragraph as follows:—

(aa) pharmaceutical services to be provided in the neighbourhood at these premises by any person whose name is included in the provisional pharmaceutical list

Section 9 Amendment of Schedule 3A to the principal Regulations

For Part III of Schedule 3 to the principal Regulations there shall be substituted that Part as set out in the Schedule to these Regulations.

Section 10 Transitional

Any application by a person for inclusion in the pharmaceutical list, received by a Health Board on or after 7th November 1989, shall be determined in accordance with the principal Regulations as amended by these Regulations and any application so received before that date shall be determined in accordance with the principal Regulations as then in force.